ctrl K

Watchlist Price Alert

Reneo Pharmaceuticals Inc... (RPHM)

NASDAQ: RPHM · Real-Time Price · USD

18.20

16.47 (952.02%)

At close: Oct 04, 2024, 8:00 PM

Reneo Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.63M	19.93M	124.66M	53.61M	17.5M
Short-Term Investments	75.33M	81.25M	23.01M	n/a	7.39M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	81K	84K	78K	127K	20K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.66M	5.18M	6.06M	n/a	n/a
Total Current Assets	106.62M	106.35M	153.73M	55.02M	25.41M
Property-Plant & Equipment	733K	1.75M	212K	69K	79K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	814K	1.83M	290K	196K	99K
Total Assets	107.44M	108.18M	154.02M	55.22M	25.5M
Account Payables	8.72M	1.89M	2.02M	908K	542K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	331K	404K	n/a	n/a	n/a
Other Current Liabilities	3.62M	403K	n/a	n/a	n/a
Total Current Liabilities	18.18M	7.12M	6.2M	4.58M	2.94M
Long-Term Debt	n/a	n/a	n/a	92.72M	45.65M
Other Long-Term Liabilities	7K	29K	611K	n/a	n/a
Total Long-Term Liabilities	649K	1.09M	611K	92.76M	45.69M
Total Liabilities	18.83M	8.21M	6.81M	97.34M	48.63M
Total Debt	973K	1.46M	n/a	92.72M	45.65M
Common Stock	3K	3K	3K	1K	1K
Retained Earnings	-218.47M	-136.68M	-84.73M	-44.96M	-25.49M
Comprehensive Income	8K	-43K	34K	-93.72K	3K
Shareholders Equity	88.61M	99.97M	147.21M	-42.12M	-23.13M
Total Investments	75.33M	81.25M	23.01M	n/a	7.39M